1Soura E, Chasapi V, Stratigos AJ. Pharmacologic treatment options for advanced epithelial skin cancer. Expert Opin Pharmacother 2015; 16: 1479–93.
10.1517/14656566.2015.1052743
CAS PubMed Web of Science® Google Scholar
2Robert C, Schachter J, Long GV et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015; 372: 2521–32.
10.1056/NEJMoa1503093
CAS PubMed Web of Science® Google Scholar
3Nghiem PT, Bhatia S, Lipson EJ et al. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma. N Engl J Med 2016; 374: 2542–52.
10.1056/NEJMoa1603702
CAS PubMed Web of Science® Google Scholar
4Alexandrov LB, Nik-Zainal S, Wedge DC et al. Signatures of mutational processes in human cancer. Nature 2013; 500: 415–21.
10.1038/nature12477
CAS PubMed Web of Science® Google Scholar
5Belai EB, de OC, Gasparoto TH et al. PD-1 blockage delays murine squamous cell carcinoma development. Carcinogenesis 2014; 35: 424–31.
10.1093/carcin/bgt305
CAS PubMed Web of Science® Google Scholar
6Winkler JK, Schneiderbauer R, Bender C et al. Anti-programmed cell death-1 therapy in nonmelanoma skin cancer. Br J Dermatol 2016; doi: 10.1111/bjd.14664.
10.1111/bjd.14664
Web of Science® Google Scholar
7Chang AL, Kim J, Luciano R et al. A case report of unresectable cutaneous squamous cell carcinoma responsive to pembrolizumab, a programmed cell death protein 1 inhibitor. JAMA Dermatol 2016; 152: 106–8.
10.1001/jamadermatol.2015.2705
PubMed Web of Science® Google Scholar
8Borradori L, Sutton B, Shayesteh P, Daniels GA. Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases. Br J Dermatol 2016; 175: 1382–86.
10.1111/bjd.14642
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume175, Issue6

December 2016

Pages 1150-1151

Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise

Abstract

References

Citing Literature

References

Related

Information